Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1Phase 2/3 1Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Weight Loss 1Ovarian Neoplasms 1Neoplasms 1Neoplasm Metastasis 1Motor Activity 1Lung Neoplasms 1Carcinoma, Ovarian Epithelial 1Carcinoma, Intraductal, Noninfiltrating 1Cachexia 1Breast Neoplasms 1Body Weight 1

Interventions

anamorelin 2Mirtazapine 2Tirzepatide 1Olanzapine 1Octreotide 1Nutritionists 1Nutrition Assessment 1Flurandrenolone 1Exercise 1EOM613 1Diet, Carbohydrate-Restricted 1Diet 1Acetylcysteine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Weight Loss × Nutrition Assessment × Clear all
NCT03035409 2025-11-10

Anamorelin Hydrochloride, Physical Activity, and Nutritional Counseling in Decreasing Cancer-Related Fatigue in Patients With Incurable Metastatic or Recurrent Solid Tumors

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
129 enrolled 11 charts

Neoplasm Metastasis, Weight Loss

Data powered by HemOnc (CC BY 4.0) Colophon âš¡